We are live on
!
Find out more
IC
Institutional Capital Portfolio holdings
AUM
$6.75B
1-Year Est. Return
3.44%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
+3.44%
3 Year Est. Return
+8.86%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.4B
AUM Growth
–
Cap. Flow
+$19.4B
Cap. Flow
% of AUM
100.31%
Top 10 Holdings %
Top 10 Hldgs %
43.84%
Holding
43
New
43
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Pfizer
PFE
|
+$1.22B |
| 2 |
GE Aerospace
GE
|
+$1.07B |
| 3 |
ExxonMobil
XOM
|
+$901M |
| 4 |
Vodafone
VOD
|
+$896M |
| 5 |
Johnson & Johnson
JNJ
|
+$883M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 23.38% |
| 2 | Financials | 15.53% |
| 3 | Communication Services | 13.66% |
| 4 | Energy | 12.52% |
| 5 | Industrials | 12.1% |
Similar funds
EAM
MFS
CIM
KAM
PFM
WC
BWM
TM
Institutional Capital's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Institutional Capital, which disclosed 43 positions worth $19.4B. Its ten largest holdings account for 44% of the portfolio.
Its largest position is Pfizer: 44,082,069 shares worth $1.17B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Financials and Communication Services.
- Institutional Capital's largest Q2 2013 buy was Pfizer: 44,082,069 shares worth $1.17B.
- Institutional Capital's ten largest holdings make up 44% of its $19.4B portfolio in Q2 2013.
- Institutional Capital disclosed 43 positions in Q2 2013, its first 13F filing on record.
Based on Institutional Capital's 13F filing for Q2 2013, filed 13 Aug 2013.